Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03515889 · ClinicalTrials.gov registry record · NA

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss

A NA study, sponsored by Tulane University.

Completed
Registry status
NA
Development phase
192
Enrollment target

NCT03515889: Completed NA study, sponsored by Tulane University.

NCT03515889 is a NA study that has completed, run by Tulane University. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03515889, a NA study, has completed, sponsored by Tulane University.

COMPLETED
Registry status
NA
Development phase
192 participants
Enrollment target

Study Summary

This study will examine whether, compared to a standard, low-fat, calorie-restricted diet intervention, the clinic-supported Ideal Protein weight loss method will result in greater weight loss and improvement in cardiometabolic risk factors over 3 months among obese adults with cardiovascular disease (CVD) risk factors.

Primary Outcome

Change in weight at follow-up

Interventions

  • BEHAVIORAL Ideal Protein Weight Loss Method
  • BEHAVIORAL Standard Weight Loss

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2018-05-23
Est. Completion 2020-09-30
Phase NA
Tulane University

73 total trials

What the finished NCT03515889 record still lists

NCT03515889 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Ideal Protein Weight Loss Method is the first listed.

NCT03515889 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03515889 about?

NCT03515889 is a clinical study titled "A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss". This study will examine whether, compared to a standard, low-fat, calorie-restricted diet intervention, the clinic-supported Ideal Protein weight loss method will result in greater weight loss and improvement in cardiometabolic risk factors over 3 months among obese adults with cardiovascular diseas...

What is the current status of trial NCT03515889?

This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2018-05-23. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT03515889?

The interventions under investigation include: Ideal Protein Weight Loss Method (BEHAVIORAL), Standard Weight Loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT03515889?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03515889's enrollment target sits among peer trials

192 570th of 2000 higher than 1,427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03515889, the US trial registry maintained by the National Library of Medicine. NCT03515889 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.